Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evolution of renal function abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy.
Cohen MP, Clements RS, Hud E, Cohen JA, Ziyadeh FN. Cohen MP, et al. Among authors: hud e. Exp Nephrol. 1996 May-Jun;4(3):166-71. Exp Nephrol. 1996. PMID: 8773479
Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin.
Lautenslager GT, Shearman CW, Hud E, Cohen MP. Lautenslager GT, et al. Among authors: hud e. Metabolism. 2011 Dec;60(12):1683-91. doi: 10.1016/j.metabol.2011.03.022. Epub 2011 May 31. Metabolism. 2011. PMID: 21632076
Amelioration of diabetes-associated abnormalities in the vitreous fluid by an inhibitor of albumin glycation.
Cohen MP, Hud E, Wu VY, Shearman CW. Cohen MP, et al. Among authors: hud e. Invest Ophthalmol Vis Sci. 2008 Nov;49(11):5089-93. doi: 10.1167/iovs.08-1993. Epub 2008 Jul 3. Invest Ophthalmol Vis Sci. 2008. PMID: 18599566
Vitreous fluid of db/db mice exhibits alterations in angiogenic and metabolic factors consistent with early diabetic retinopathy.
Cohen MP, Hud E, Shea E, Shearman CW. Cohen MP, et al. Among authors: hud e. Ophthalmic Res. 2008;40(1):5-9. doi: 10.1159/000111151. Epub 2007 Nov 20. Ophthalmic Res. 2008. PMID: 18025835
Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency.
Cohen MP, Lautenslager GT, Hud E, Shea E, Wang A, Chen S, Shearman CW. Cohen MP, et al. Among authors: hud e. Am J Physiol Renal Physiol. 2007 Feb;292(2):F789-95. doi: 10.1152/ajprenal.00201.2006. Epub 2006 Oct 3. Am J Physiol Renal Physiol. 2007. PMID: 17018845 Free article.
Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-beta1.
Cohen MP, Ziyadeh FN, Hong SW, Shearman CW, Hud E, Lautenslager GT, Iglesias-de la Cruz MC, Chen S. Cohen MP, et al. Among authors: hud e. Kidney Int. 2002 Jun;61(6):2025-32. doi: 10.1046/j.1523-1755.2002.00352.x. Kidney Int. 2002. PMID: 12028443 Free article.
Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice.
Cohen MP, Hud E, Shea E, Shearman CW. Cohen MP, et al. Among authors: hud e. Metabolism. 2002 Jul;51(7):901-5. doi: 10.1053/meta.2002.33359. Metabolism. 2002. PMID: 12077739
Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.
Cohen MP, Chen S, Ziyadeh FN, Shea E, Hud EA, Lautenslager GT, Shearman CW. Cohen MP, et al. Among authors: hud ea. Kidney Int. 2005 Oct;68(4):1554-61. doi: 10.1111/j.1523-1755.2005.00567.x. Kidney Int. 2005. PMID: 16164632 Free article.
Glycated albumin: a marker of glycaemic status in rats with experimental diabetes.
Neuman RG, Hud E, Cohen MP. Neuman RG, et al. Among authors: hud e. Lab Anim. 1994 Jan;28(1):63-9. doi: 10.1258/002367794781065663. Lab Anim. 1994. PMID: 8158971
Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin.
Cohen MP, Hud E, Wu VY. Cohen MP, et al. Among authors: hud e. Kidney Int. 1994 Jun;45(6):1673-9. doi: 10.1038/ki.1994.219. Kidney Int. 1994. PMID: 7933815
17 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback